| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Tango Therapeutics, Inc. (TNGX) have been net sellers, shedding 89,200 shares worth roughly $2.2M on balance. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), TNGX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.63M | $21.01M | - | |
| CEO | 367.5K | - | - | |
| CFO | 184.3K | $2.26M | - | |
| Pres | 115.7K | $2.93M | -27,000 | |
| Other | 59.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $24.47 | $660,796.08 | -18.9% | - | - | |
| Sep 22, 2026 | Newcomb Jessica | Principal Accounting Officer | Sell | 8,200 | $24.22 | $198,612.68 | -12.2% | - | - | |
| Sep 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $22.37 | $603,909.00 | -18.9% | - | - | |
| Aug 3, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $27.24 | $735,517.41 | -18.9% | - | - | |
| Jul 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $29.59 | $798,908.18 | -18.9% | -15.0% | - | |
| Jun 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $22.87 | $617,571.27 | -18.9% | -1.1% | - | |
| May 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $21.23 | $573,097.33 | -18.9% | +31.4% | - | |
| Apr 15, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 38,460 | $25.00 | $961,500.00 | -25.5% | +17.1% | - | |
| Apr 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $21.20 | $572,478.30 | -19.3% | +47.3% | - | |
| Mar 25, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 12,000 | $20.11 | $241,320.00 | -9.6% | +36.0% | - |